Search

everythinglearnresearchcommunity

for

Search:↓

SLE significantly affects daily life, especially through fatigue and joint pain, highlighting the need for better treatments.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

Joint replacement surgery normalized high alkaline phosphatase levels in a patient with severe osteoarthritis.

Both azathioprine and betamethasone treatments effectively regrow hair in alopecia areata, but azathioprine may be safer.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.

Platelet-rich plasma is more effective and satisfactory than hyaluronic acid for knee osteoarthritis.

The mRNA-1273 COVID-19 vaccine may worsen symptoms in people with systemic lupus erythematosus.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

Most patients with Systemic Lupus Erythematosus experience fatigue, skin issues, and joint pain.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

The patient improved after antiviral treatment for a viral infection.

Alopecia areata is linked to autoimmune antibodies.

Intralesional steroids effectively treated a young female's scalp nodules without recurrence.

Autoimmune polyglandular syndrome can cause temporary brain issues that may improve on their own.

People with alopecia areata have more inflammation but similar heart risk as healthy people.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

RDW can be a useful marker for inflammation in alopecia areata patients.

Early diagnosis and treatment of systemic-onset juvenile idiopathic arthritis are crucial for improvement.

A woman with lupus had unusual symptoms like blisters, skin inflammation, and throat ulcers, which improved with steroid and dapsone treatment.

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Higher inflammation markers are linked to more severe alopecia areata.